Highlights

• Cochlear shares rose 2.47% to AUD 97.35 on 24 April 2026 despite a significant downgrade to FY26 earnings guidance.
• Softer-than-expected demand in developed markets and Middle East uncertainty pressured near-term growth expectations.
• Services and Acoustics segments continue to deliver solid growth, partially offsetting implant weakness.
• The company remains focused on long-term expansion through innovation, cost restructuring, and growth in the adult and seniors segment.

Cochlear Ltd, a global leader in implantable hearing solutions, has come under renewed investor scrutiny following a trading update that highlighted weakening near-term demand and a substantial downgrade to…